PT  - JOURNAL ARTICLE
ED  - ,
TI  - Chemotherapy and non-small-cell lung cancer
AID  - 10.1136/dtb.2002.4029
DP  - 2002 Feb 01
TA  - Drug and Therapeutics Bulletin
PG  - 9--11
VI  - 40
IP  - 2
4099  - http://dtb.bmj.com/content/40/2/9.short
4100  - http://dtb.bmj.com/content/40/2/9.full
SO  - Drug Ther Bull2002 Feb 01; 40
AB  - Relevant BNF section: 8.1Around 34,000 people in the UK die from lung cancer each year.1 Over 75% of patients with the disease have non-small-cell lung cancer (NSCLC). Here, we discuss the role of chemotherapy in the management of NSCLC, a treatment that some medical oncologists estimate would benefit 50% of patients with NSCLC,2 but which is given to fewer than 10%.3